Key facts
- This page summarizes Patrick G. Enright's Form 4 filing for Jazz Pharmaceuticals plc (JAZZ).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 08 Jan 2026, 17:56.
Patrick G. Enright - 18 Aug 2025 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)
- Reporting relationship
- Director
- Issuer ticker
- JAZZ
- Reported as of
- 18 Aug 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 08 Jan 2026, 17:56:44 UTC
- Prior SEC filing
- 11 Aug 2025
- Next SEC filing
- 14 Oct 2025
- Source filing
- View source filing
- Reporting owner signature
- By: /s/Paz Dizon, as attorney in fact For: Patrick Enright
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Patrick G. Enright filed Form 4 for Jazz Pharmaceuticals plc (JAZZ) on 08 Jan 2026.
Change
- Previous filing in this sequence was filed on 11 Aug 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001253886
Primary reporting owner
ENRIGHT PATRICK G
- Relationship
- Director
- Address
- 5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN 4, IRELAND
- Signature
- By: /s/Paz Dizon, as attorney in fact For: Patrick Enright
- Signature date
- 08 Jan 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
JAZZ
transaction
Ordinary Shares
Other
- Transaction value
- $0
- Shares
- -5,000
- Change %
- -19%
- Price
- $0.000000
- Shares after
- 21,379
- Date
- 18 Aug 2025
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Shares transferred to former spouse without consideration as part of a comprehensive division of marital assets. Following the transfer, the reporting person no longer has beneficial ownership of the transferred shares.